ArticleHepatology communications2026

Lower circulating angiotensinogen levels across ACLD stages are associated with hepatic dysfunction and mortality.

Marlene Hintersteininger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.